DERM
NASDAQ · Pharmaceuticals
Journey Medical Corp
$5.17
-0.24 (-4.44%)
Open$5.37
Previous Close$5.41
Day High$5.37
Day Low$5.10
52W High$9.56
52W Low$4.25
Volume—
Avg Volume177.0K
Market Cap126.16M
P/E Ratio—
EPS$-0.23
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+202.9% upside
Current
$5.17
$5.17
Target
$15.66
$15.66
$10.95
$15.66 avg
$21.05
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 61.62M | 65.31M | 106.46M |
| Net Income | -11,386,397 | -10,862,579 | 19.04M |
| Profit Margin | -18.5% | -17.6% | 17.9% |
| EBITDA | -3,899,584 | -3,926,865 | 19.03M |
| Free Cash Flow | — | — | 11.82M |
| Rev Growth | -5.7% | -5.7% | +23.5% |
| Debt/Equity | 0.79 | 0.79 | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |